When digestion feels better, life feels better

Published: 10-Mar-2026

Beyond gut relief: how Poolzyme Multi supports emotional wellbeing through improved digestive function

Digestive discomfort is rarely just a physical issue. For many consumers, persistent upper gastrointestinal symptoms can profoundly affect daily life, influencing mood, motivation and emotional resilience. As the nutraceutical industry continues to embrace a more holistic view of health, the connection between digestive function and emotional wellbeing is gaining increasing attention.

Functional dyspepsia is a clear example of this interplay. It is often accompanied by feelings of anxiety and low mood. Supporting digestion in these individuals may therefore offer benefits that extend beyond symptom relief, reaching into the emotional sphere.

Poolzyme® Multi, a broad-spectrum enzyme blend with demonstrated mechanistic efficacy in supporting macronutrients digestion, has recently been evaluated in a randomised, double-blind, placebo-controlled clinical trial involving subjects with functional dyspepsia. While the primary focus of digestive enzyme supplementation is typically gastrointestinal comfort, this study also explored quality of life outcomes using the Nepean Dyspepsia Index (NDI), a validated tool that includes a dedicated emotional wellbeing domain, and PSQI, a tool that evaluates sleep quality.

The emotional domain of the NDI assesses how digestive problems affect general emotional wellbeing, feelings of anxiety and nervousness, depressive mood, irritability and daily motivation. Over a 60-day supplementation period with Poolzyme® Multi, participants reported a progressive and statistically significant improvement across these emotional parameters.

These improvements were already evident after 30 days of supplementation, highlighting a relatively rapid impact. After 60 days, additional benefits emerged in anxiety-related perceptions and motivation to engage in everyday activities. Collectively, these changes reflect a meaningful shift in how individuals emotionally experience and manage their digestive condition.

Importantly, participants moved from reporting more severe emotional distress towards milder levels, with some measures indicating a transition from moderate emotional impact to minimal interference in daily life. In contrast, the placebo group showed no significant change over the same time frame, reinforcing the relevance of Poolzyme® Multi support in this context.

Improvements were also observed in sleep quality from the first month of supplementation. By the end of the study, PSQI scores of Poolzyme® Multi group were reduced by 27.7% versus both baseline and placebo.

These findings align with the growing understanding of the gut–brain axis, where digestive efficiency and comfort play a role in emotional balance. By supporting physiological digestion, Poolzyme® Multi may help reduce the emotional strain associated with digestive discomfort, contributing to a more positive and empowered sense of wellbeing. This broader perspective is increasingly shaping how digestive health is defined and communicated within the nutraceutical industry.

As consumer expectations continue to evolve, digestive health is no longer viewed as a purely functional category. Today’s market increasingly values solutions that support comfort, sleep, emotional balance and everyday quality of life in an integrated way. Ingredients such as Poolzyme® Multi reflect this shift, offering formulators the opportunity to address digestive wellbeing through a broader, more holistic narrative. In this context, clinically substantiated digestive enzyme blends are well positioned to become key enablers of next-generation gut health concepts that resonate with both science-driven brands and emotionally aware consumers.


References

  1. Ullah H, Di Minno A, Piccinocchi R, Buccato DG, De Lellis LF, Baldi A, El-Seedi HR, Khalifa SAM, Piccinocchi G, Xiao X, Sacchi R, Daglia M. Efficacy of digestive enzyme supplementation in functional dyspepsia: A monocentric, randomized, double-blind, placebo-controlled, clinical trial. Biomed Pharmacother. 2023 Dec 31;169:115858.
  2. Robin Duncan R., Mantegazza G., Gardana C., Angelini F., Russo R., Guglielmetti S., Simulated gastrointestinal digestion of two convenience meals using fungal enzyme formulations. Food Bioscience. 2025; 71: 107283.

You may also like